ZBH

Zimmer Holdings Inc.

Healthcare


Presented:10/17/2014
Price:$97.52
Cap:$16.50B
Current Price:$104.60
Cap:$21.64B

Presented

Date10/17/2014
Price$97.52
Market Cap$16.50B
Ent Value$16.46B
P/E Ratio28.77x
Book Value$38.42
Div Yield0.7%
Shares O/S168.92M
Ave Daily Vol1,170,000
Short Int2.94%

Current

Price$104.60
Market Cap$21.64B
Zimmer Holdings, Inc., through its subsidiaries, designs, develops, manufactures, and markets orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The company offers orthopedic reconstructive devices that restore function lost due to disease or trauma in joints such as knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. It also provides related surgical products comprising surgical supplies and instruments designed to aid in orthopedic surgical procedures and post-operation rehabilitation; and other healthcare related services. The company’s principal customers include orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers, as well as agents, healthcare purchasing organizations, or buying groups. Zimmer Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Publicly traded companies mentioned herein: Zimmer Holdings Inc (ZBH)

Highlights

The presenter is long shares of Zimmer Holdings (ZBH) and believes the synergies from the deal with Biomet will be sufficient to drive pro forma EPS to $9 in 2016. General fear/ concern about pricing headwinds is well founded; however, the issue is well known and may be priced in to the stock at present levels (~$95).

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.